chr5-140674013-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_002109.6(HARS1):c.*244A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000785 in 594,546 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00088 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00075 ( 2 hom. )
Consequence
HARS1
NM_002109.6 3_prime_UTR
NM_002109.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.144
Genes affected
HARS1 (HGNC:4816): (histidyl-tRNA synthetase 1) Aminoacyl-tRNA synthetases are a class of enzymes that charge tRNAs with their cognate amino acids. The protein encoded by this gene is a cytoplasmic enzyme which belongs to the class II family of aminoacyl-tRNA synthetases. The enzyme is responsible for the synthesis of histidyl-transfer RNA, which is essential for the incorporation of histidine into proteins. The gene is located in a head-to-head orientation with HARSL on chromosome five, where the homologous genes share a bidirectional promoter. The gene product is a frequent target of autoantibodies in the human autoimmune disease polymyositis/dermatomyositis. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 5-140674013-T-C is Benign according to our data. Variant chr5-140674013-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 1200823.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00088 (134/152278) while in subpopulation NFE AF = 0.000588 (40/68014). AF 95% confidence interval is 0.000444. There are 0 homozygotes in GnomAd4. There are 82 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position FAILED quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000881 AC: 134AN: 152160Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
134
AN:
152160
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000753 AC: 333AN: 442268Hom.: 2 Cov.: 0 AF XY: 0.000712 AC XY: 168AN XY: 236010 show subpopulations
GnomAD4 exome
AF:
AC:
333
AN:
442268
Hom.:
Cov.:
0
AF XY:
AC XY:
168
AN XY:
236010
Gnomad4 AFR exome
AF:
AC:
0
AN:
12318
Gnomad4 AMR exome
AF:
AC:
8
AN:
20286
Gnomad4 ASJ exome
AF:
AC:
0
AN:
13608
Gnomad4 EAS exome
AF:
AC:
0
AN:
29540
Gnomad4 SAS exome
AF:
AC:
2
AN:
46192
Gnomad4 FIN exome
AF:
AC:
170
AN:
28194
Gnomad4 NFE exome
AF:
AC:
137
AN:
265024
Gnomad4 Remaining exome
AF:
AC:
16
AN:
25208
Heterozygous variant carriers
0
15
30
46
61
76
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000880 AC: 134AN: 152278Hom.: 0 Cov.: 33 AF XY: 0.00110 AC XY: 82AN XY: 74454 show subpopulations
GnomAD4 genome
AF:
AC:
134
AN:
152278
Hom.:
Cov.:
33
AF XY:
AC XY:
82
AN XY:
74454
Gnomad4 AFR
AF:
AC:
0.0000240662
AN:
0.0000240662
Gnomad4 AMR
AF:
AC:
0.000392054
AN:
0.000392054
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0.00809031
AN:
0.00809031
Gnomad4 NFE
AF:
AC:
0.000588114
AN:
0.000588114
Gnomad4 OTH
AF:
AC:
0.00047259
AN:
0.00047259
Heterozygous variant carriers
0
9
18
28
37
46
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
May 18, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at